Aerospace and defense company Cadre (NYSE: CDRE) fell short of the market’s revenue expectations in Q4 CY2025, with sales falling 5% year on year to $167.2 million. On the other hand, the company’s full-year revenue guidance of $747 million at the midpoint came in 0.8% above analysts’ estimates. Its non-GAAP profit of $0.29 per share was 37.4% below analysts’ consensus estimates.

Is now the time to buy CDRE? Find out in our full research report (it’s free for active Edge members).

StockStory’s Take

Cadre’s fourth quarter was marked by revenue and margin declines, missing Wall Street expectations and prompting a sharp negative market reaction. Management attributed underperformance to timing shifts in large defense and nuclear contracts, distribution softness, and a temporary slowdown in certain nuclear projects following regulatory changes. CFO Blaine Browers acknowledged the impact of these delays, while CEO Warren Kanders emphasized ongoing demand for core public safety and defense offerings. The company also cited ongoing integration of recent acquisitions and highlighted a growing order backlog as a positive sign.

Looking ahead, Cadre’s guidance is shaped by a mix of optimism about new contract wins and caution around near-term nuclear market headwinds. Management expects public safety and defense categories to see continued demand, driven by recent wins such as the Med-Eng blast seat contract, while the nuclear segment faces short-term volume and margin pressure from shifts in federal decommissioning priorities. President Brad Williams stated, “We expect strong demand in 2026 across our core markets,” but also noted that normalization in nuclear project timing will be needed for segment growth to accelerate.

Key Insights from Management’s Remarks

Management pointed to integration of acquisitions, shifts in customer funding priorities, and strong contract wins as key factors shaping the latest quarter and the outlook.

• Acquisition integration progress: The addition of CARS Engineering and TIER Tactical expanded Cadre’s capabilities in nuclear safety and protective equipment. Management emphasized the complementary nature of TIER’s international defense customer base and engineering expertise, and noted that integration projects to leverage TIER’s manufacturing across Cadre’s business units are underway.

• Large contract wins drive backlog: Significant multi-year deals, including a $50 million blast exposure monitoring system and an $86 million blast attenuation seat contract for military vehicles, contributed to a nearly 50% year-on-year increase in order backlog. These contracts are expected to provide revenue visibility and support growth in the public safety and defense segments over the next several years.

• Nuclear market headwinds: The nuclear segment was pressured by a federal executive order slowing plutonium down blending, which reduced demand for some high-margin safety products. Management described this as a near-term headwind but expects growth to resume as commercial nuclear opportunities emerge and the backlog for containment and alarm systems builds.

• Distribution and run-rate softness: The company experienced lower distribution revenue and some softness in run-rate product lines during the quarter, which, combined with timing delays, weighed on overall results. However, management noted continued growth in consumer channels, particularly for the Safariland brand.

• Active M&A pipeline: Cadre continues to pursue additional acquisitions in its core markets, with a focus on businesses offering strong margins and recurring revenue. Management emphasized a disciplined approach and expects further portfolio expansion to drive long-term growth.

Drivers of Future Performance

Cadre’s 2026 outlook is shaped by expectations for recovering public safety demand, gradual improvement in nuclear markets, and ongoing integration of recent acquisitions.

• Public safety and defense growth: Management expects core segments such as duty gear, armor, and sensor technology to benefit from strong order backlog and new contract wins, particularly as delayed projects are fulfilled and international opportunities expand. The integration of TIER Tactical is anticipated to enhance product offerings and open access to additional global defense customers.

• Nuclear segment recovery: While the nuclear group faces near-term margin and volume pressure due to the shift away from plutonium down blending, management believes growth in commercial nuclear containment and alarm system projects will offset these declines over time. The company is closely monitoring federal policy developments and project timing to assess when segment performance will normalize.

• M&A-driven expansion: Cadre maintains a robust pipeline of potential acquisitions, targeting specialized safety technology businesses with defensible market positions. Management sees further M&A as critical to broadening the portfolio, increasing customer wallet share, and maintaining steady revenue growth.

Catalysts in Upcoming Quarters

Looking forward, the StockStory team is monitoring (1) the pace at which delayed defense and nuclear contracts convert to revenue, (2) the ramp-up and integration of TIER Tactical’s products and customer relationships across Cadre’s business units, and (3) signs of recovery in nuclear safety product demand as federal policy priorities evolve. M&A execution and margin stabilization will also be critical signposts for future results.

Cadre currently trades at $34.76, down from $40.69 just before the earnings. Is the company at an inflection point that warrants a buy or sell? Find out in our full research report (it’s free).

Stocks That Trumped Tariffs

ONE MORE THING: Top 6 Stocks for This Week. This market is separating quality stocks from expensive ones fast. AI taking down whole sectors with no warning. In a rotation this fast, you need more than a list of good companies.

Our AI system flagged Palantir before it ran 1,662%. AppLovin before it ran 753%. Nvidia before it ran 1,178%. Each week it produces 6 new names that pass the same tests. Get Our Top 6 Stocks for Free HERE.

Stocks that have made our list include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.